Meningococcal Disease Treatment Market
- 2026 年市場規模
- USD 10.2 Bn
- 2033 年預估規模
- USD 28.3 Bn
- 年複合成長率 CAGR
- 13.2%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Meningococcal Disease Treatment Market, By Therapy Type (Antibiotics (Penicillin, Ampicillin, Chloramphenicol, and Ceftriaxone) and Vaccines (Bivalent, Trivalent, and Tetravalent)), By Route of Administration (Injectable and Oral), By Distribution channel (Hospital Pharmacy, Retail Pharmacy, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Meningococcal infection is a bacterial infection caused by Neisseria meningitidis, also known as meningococcus, a gram-negative bacterium. Meningococcal meningitis is a serious infection of the thin lining that surrounds the brain and spinal cord.
Furthermore, according to the World Health Organization Meningococcal meningitis is observed worldwide but the highest burden of the disease is in the meningitis belt of sub-Saharan Africa, stretching from Senegal in the west to Ethiopia in the east. Around 30,000 cases are still reported each year from that area.
Market Dynamics
The global meningococcal disease treatment market is expected to witness significant growth during the forecast period owing to the increasing prevalence of meningococcal disease. According to the centers for disease control and prevention, there were about 330 total cases of meningococcal disease reported in the U.S. in 2018.
Key features of the study
• This report provides in-depth analysis of the global meningococcal disease treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global meningococcal disease treatment market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study are GlaxoSmithKline Plc., Novartis AG, Sanofi Pasteur Inc., Wockhardt Ltd., Kent Pharmaceuticals, Stravencon Limited., F. Hoffmann-La Roche Ltd., Athlone Laboratories, and Pfizer Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global meningococcal disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global meningococcal disease treatment market
Market Segmentation
• By Therapy Type
o Antibiotics
Penicillin
Ampicillin
Chloramphenicol
Ceftriaxone
o Vaccines
Bivalent
Trivalent
Tetravalent
• By Route of Administration
o Injectable
o Oral
• By Distribution channel
o Hospital Pharmacy
o Retail Pharmacy
o Others
• By Regional Insights
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o GlaxoSmithKline Plc.
o Novartis AG
o Sanofi Pasteur Inc.
o Wockhardt Ltd.
o Kent Pharmaceuticals
o Stravencon Limited.
o Hoffmann-La Roche Ltd.
o Athlone Laboratories
o Pfizer Inc.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Therapy Type
Market Snippet, By Route of Administration
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Regulatory Scenario
o Impact Analysis
o PEST Analysis
o Technological Advancements
o Market Trends
o Key Developments
o New Launches and Approval
4. Global Meningococcal Disease Treatment Market, By Therapy Type, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o Antibiotics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Penicillin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Ampicillin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Chloramphenicol
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Ceftriaxone
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Bivalent
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Trivalent
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Tetravalent
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Meningococcal Disease Treatment Market, By Route of Administration, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o Injectable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Meningococcal Disease Treatment Market, By Distribution Channel, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others
Introduction
Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Meningococcal Disease Treatment Market, By Region, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2021-2033
o North America
Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2021-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2021-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2021-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2021-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2021-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2021-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o South Africa
o Central Africa
o North Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
GlaxoSmithKline Plc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Novartis AG
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Sanofi Pasteur Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Wockhardt Ltd.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Kent Pharmaceuticals
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Stravencon Limited.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Hoffmann-La Roche Ltd.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Athlone Laboratories
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Pfizer Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
9. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們